BridgeMD
New treatment option for Gestational Hypertension
Official title Vagal Stimulation Therapy and Preeclampsia
ClinicalTrials.gov ID: NCT06953115
What this study is testing
- What it's testing
- Preeclampsia is one of the most common and serious complications of pregnancy, affecting both the mother and baby. It is a condition characterized by high blood pressure and can lead to severe complications, including neurological issues and reduced blood flow to the placenta.
- Time commitment: about 12 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Outpatient female patients over 18 years old, attending their first appointment and seen in the obstetrics outpatient clinic at the Regional General...
- No prior treatment.
- Willing to participate by signing an informed consent form.
You likely can't join if
- Patients with chronic hypertension.
- Concomitant organ dysfunction.
- Immunological diseases.
- Patients with severe preeclampsia or chronic conditions concomitant with pregnancy.
- Patients with gestational trophoblastic disease requiring uterine evacuation or choriocarcinoma associated with hypertension.
The study team makes the final eligibility decision.
Where it's taking place
- Guadalajara, Jalisco, Mexico
- Tlajomulco de Zúñiga, Jalisco, Mexico
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guadalajara, Jalisco, Mexico; Tlajomulco de Zúñiga, Jalisco, Mexico. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.